Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells

被引:123
作者
Morra, M [1 ]
Lu, J
Poy, F
Martin, M
Sayos, J
Calpe, S
Gullo, C
Howie, D
Rietdijk, S
Thompson, A
Coyle, AJ
Denny, C
Yaffe, MB
Engel, P
Eck, MJ
Terhorst, C
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
[4] Millennium Pharmaceut Inc, Inflammat Div, Cambridge, MA 02139 USA
[5] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[6] MIT, Dept Biol, Cambridge, MA 02139 USA
[7] Univ Barcelona, Fac Med, Dept Cellular Biol & Pathol, E-08007 Barcelona, Spain
关键词
antigen-presenting cells; crystal structure; EAT-2; SAP; XLP;
D O I
10.1093/emboj/20.21.5840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The T and natural killer (NK) cell-specific gene SAP (SH2D1A) encodes a 'free SH2 domain' that binds a specific tyrosine motif in the cytoplasmic tail of SLAM (CD150) and related cell surface proteins. Mutations in SH2D1A cause the X-linked lymphoproliferative disease, a primary immunodeficiency. Here we report that a second gene encoding a free SH2 domain, EAT-2, is expressed in macrophages and B lympho cytes. The EAT-2 structure in complex with a phosphotyrosine peptide containing a sequence motif with Tyr281 of the cytoplasmic tail of CD150 is very similar to the structure of SH2D1A complexed with the same peptide. This explains the high affinity of EAT-2 for the pTyr motif in the cytoplasmic tail of CD150 but, unlike SH2D1A, EAT-2 does not bind to non-phosphorylated CD150. EAT-2 binds to the phosphorylated receptors CD84, CD150, CD229 and CD244, and acts as a natural inhibitor, which interferes with the recruitment of the tyrosine phosphatase SHP-2. We conclude that EAT-2 plays a role in controlling signal transduction through at least four receptors expressed on the surface of professional antigen-presenting cells.
引用
收藏
页码:5840 / 5852
页数:13
相关论文
共 53 条
  • [1] ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
  • [2] AUSUBEL FM, 1995, CURRENT PROTOCOLS S, V17
  • [3] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [4] Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease
    Benoit, L
    Wang, XX
    Pabst, HF
    Dutz, J
    Tan, R
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (07) : 3549 - 3553
  • [5] Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)
    Brandau, O
    Schuster, V
    Weiss, M
    Hellebrand, H
    Fink, FM
    Kreczy, A
    Friedrich, W
    Strahm, B
    Niemeyer, C
    Belohradsky, BH
    Meindl, A
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (13) : 2407 - 2413
  • [6] 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
    Brown, MH
    Boles, K
    van der Merwe, PA
    Kumar, V
    Mathew, PA
    Barclay, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2083 - 2090
  • [7] A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION
    COCKS, BG
    CHANG, CCJ
    CARBALLIDO, JM
    YSSEL, H
    DEVRIES, JE
    AVERSA, G
    [J]. NATURE, 1995, 376 (6537) : 260 - 263
  • [8] Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
    Coffey, AJ
    Brooksbank, RA
    Brandau, O
    Oohashi, T
    Howell, GR
    Bye, JM
    Cahn, AP
    Durham, J
    Heath, P
    Wray, P
    Pavitt, R
    Wilkinson, J
    Leversha, M
    Huckle, E
    Shaw-Smith, CJ
    Dunham, A
    Rhodes, S
    Schuster, V
    Porta, G
    Yin, L
    Serafini, P
    Sylla, B
    Zollo, M
    Franco, B
    Bolino, A
    Seri, M
    Lanyi, A
    Davis, JR
    Webster, D
    Harris, A
    Lenoir, G
    St Basile, GD
    Jones, A
    Behloradsky, BH
    Achatz, H
    Murken, J
    Fassler, R
    Sumegi, J
    Romeo, G
    Vaudin, M
    Ross, MT
    Meindl, A
    Bentley, DR
    [J]. NATURE GENETICS, 1998, 20 (02) : 129 - 135
  • [9] DANLIKER WB, 1981, METHOD ENZYMOL, V74, P3
  • [10] delaFuente MA, 1997, BLOOD, V90, P2398